The Cholesterol Controversy: What the Latest Research Shows
July 12, 20252 min read
The cholesterol paradigm is shifting from a simplistic total-cholesterol focus toward a more nuanced understanding involving LDL particle number (LDL-P), particle size, apolipoprotein B (apoB), triglyceride-to-HDL ratio, and inflammatory context — changing how we evaluate cardiovascular risk.
Beyond Total Cholesterol
Total cholesterol alone is a poor predictor of cardiovascular events — 50% of heart attacks occur in people with normal total cholesterol. More predictive markers include apoB (the protein on every atherogenic lipoprotein particle — one apoB per particle means apoB directly counts dangerous particles), LDL particle number (LDL-P — two people with the same LDL-C can have vastly different particle counts and therefore different risk), triglyceride-to-HDL ratio (a proxy for insulin resistance and small dense LDL — ratio below 2.0 suggests favorable large LDL particles; above 3.5 suggests dangerous small dense pattern), and Lp(a) (a genetically determined, highly atherogenic lipoprotein that standard lipid panels miss entirely and affects 20% of the population).
What This Means for Supplementation
If your risk is driven by high LDL-P with metabolic syndrome, berberine and bergamot address the metabolic root cause through AMPK activation and PCSK9 modulation. Berbercol combines both. If your risk is driven by elevated triglycerides, omega-3 at therapeutic doses (2-4g EPA+DHA daily) is the most effective nutritional intervention. Omega-3 Fish Oil. If inflammation is the driver (high hs-CRP with borderline lipids), anti-inflammatory strategies (omega-3, curcumin) may be more impactful than lipid-focused interventions.
Should I worry about high LDL if my other markers are good?
Context matters enormously. High LDL-C with low apoB, large particle size, low triglycerides, high HDL, and low hs-CRP represents a very different risk profile than high LDL-C with high apoB, small dense particles, and elevated inflammation. Ask your doctor for advanced lipid testing to understand your actual risk.
Does bergamot really help cholesterol?
Clinical trials show bergamot polyphenols reduce total cholesterol, LDL-C, and triglycerides while increasing HDL — comparable to low-dose statins in some studies. The mechanism involves AMPK activation and modulation of the HMG-CoA reductase and PCSK9 pathways.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
